|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/00 | |
| C07K 16/10 | |||
| C07K 16/28 | |||
| C07K 16/40 | |||
| A61K 47/68 | |||
| A61P 31/00 |
| (11) | Patento numeris | 3142700 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15793257.5 |
| Europos patento paraiškos padavimo data | 2015-05-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-03-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-03-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/030964 |
| Data | 2015-05-15 |
| (87) | Numeris | WO 2015/175874 |
| Data | 2015-11-19 |
| (30) | Numeris | Data | Šalis |
| 201461994379 P | 2014-05-16 | US |
| (72) |
TSUI, Ping, US
BORROK, Martin, US
DALL`ACQUA, William, US
WU, Yanli, US
BEYAZ-KAVUNCU, Nurten, US
|
| (73) |
Medimmune, LLC,
One Medimmune Way, Gaithersburg, Maryland 20878,
US
|
| (54) | MOLECULES WITH ALTERED NEONATE FC RECEPTOR BINDING HAVING ENHANCED THERAPEUTIC AND DIAGNOSTIC PROPERTIES |
| MOLECULES WITH ALTERED NEONATE FC RECEPTOR BINDING HAVING ENHANCED THERAPEUTIC AND DIAGNOSTIC PROPERTIES |